(IHI) iShares U.S. Medical - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US4642888105 • Health

IHI: Medical Devices, Healthcare Equipment, Surgical Instruments

The iShares U.S. Medical Devices ETF (IHI) is designed to replicate the performance of the Dow Jones U.S. Select Medical Equipment Index. This index is tailored to measure the performance of companies within the medical equipment sector in the U.S. equity market, as defined by S&P Dow Jones Indices LLC. The fund offers exposure to a diverse range of medical equipment companies, including those involved in manufacturing and distributing critical devices such as MRI scanners, prosthetics, pacemakers, X-ray machines, and other non-disposable medical devices.

As a non-diversified fund, IHI has the flexibility to concentrate its investments in a smaller number of securities, which can be beneficial for investors seeking targeted exposure to the medical devices sector. The fund is domiciled in the United States and is listed on the NYSE ARCA exchange. It is managed by BlackRock, Inc., a global leader in asset management, and provides investors with a cost-effective way to gain exposure to the medical devices industry.

With substantial assets under management totaling $5.167 billion, IHI is a significant player in the ETF landscape. The funds focus on the medical devices sector makes it an attractive option for investors looking to capitalize on the growth driven by an aging population, technological advancements, and increasing healthcare expenditure. The funds structure allows it to track the performance of its underlying index closely, providing investors with a reliable tool for accessing this dynamic sector.

Additional Sources for IHI ETF

IHI ETF Overview

Market Cap in USD 4,588m
Category Health
TER 0.40%
IPO / Inception 2006-05-01

IHI ETF Ratings

Growth Rating 37.1
Fundamental -
Dividend Rating 46.6
Rel. Strength -5.19
Analysts -
Fair Price Momentum 49.43 USD
Fair Price DCF -

IHI Dividends

Dividend Yield 12m 0.47%
Yield on Cost 5y 0.64%
Annual Growth 5y 14.79%
Payout Consistency 81.7%

IHI Growth Ratios

Growth Correlation 3m -75.5%
Growth Correlation 12m 78.4%
Growth Correlation 5y 32.2%
CAGR 5y 5.91%
CAGR/Max DD 5y 0.18
Sharpe Ratio 12m 0.48
Alpha -5.75
Beta 1.030
Volatility 33.96%
Current Volume 901.6k
Average Volume 20d 657.8k
What is the price of IHI stocks?
As of April 16, 2025, the stock is trading at USD 56.65 with a total of 901,574 shares traded.
Over the past week, the price has changed by +4.39%, over one month by -5.23%, over three months by -6.45% and over the past year by +2.33%.
Is iShares U.S. Medical a good stock to buy?
Partly, yes. Based on ValueRay Analyses, iShares U.S. Medical (NYSE ARCA:IHI) is currently (April 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 37.11 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IHI as of April 2025 is 49.43. This means that IHI is currently overvalued and has a potential downside of -12.74%.
Is IHI a buy, sell or hold?
iShares U.S. Medical has no consensus analysts rating.
What are the forecast for IHI stock price target?
According to ValueRays Forecast Model, IHI iShares U.S. Medical will be worth about 55 in April 2026. The stock is currently trading at 56.65. This means that the stock has a potential downside of -2.95%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 55 -2.9%